HSA — authorised 27 August 2012
- Marketing authorisation holder: GILEAD SCIENCES INC
- Status: likely_approved
HSA authorised Vitekta on 27 August 2012
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 27 August 2012.
GILEAD SCIENCES INC holds the Singaporean marketing authorisation.